Nasdaq Stocks

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock that can live up to its true potential can be a tough task.

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth stock is not easy at all.

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth stock is not easy at all.

Bank of America analyst upgrades Amgen, downgrades Moderna.

The Dow Jones Industrial Average is falling 814 points, or 3%. The S&P 500 is losing 2.8%, and the Nasdaq Composite is slipping 2.3%. 

The market expects Senseonics Holdings (SENS) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2019. This widely-known consensus outlook is important in assessing the company's earnings picture, but a power

Rimini Street, Inc. (RMNI) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2019. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual re

Reeds (REED) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended December 2019. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare t

AVEO Pharmaceuticals (AVEO) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2019. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual re

Broadcom Inc. (AVGO) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended January 2020. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results co

The market expects Basic Energy Services (BASX) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2019. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powe

BioDelivery Sciences International (BDSI) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2019. This widely-known consensus outlook gives a good sense of the company's earnings picture, but ho

Wall Street expects a year-over-year increase in earnings on higher revenues when Adobe Systems (ADBE) reports results for the quarter ended February 2020. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that co

Wall Street expects a year-over-year decline in earnings on higher revenues when Agenus (AGEN) reports results for the quarter ended December 2019. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impa

Aquestive Therapeutics (AQST) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended December 2019. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Thor Industries (THO). This company, which is in the Zacks Building Products - Mobile Homes and

Grifols (GRFS) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.

Hutchison China MediTech (HCM) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.

Investors might want to bet on Ingredion (INGR), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.